TCRβ+CD8+CD4+ cells, which only constituted between 0.22 and 3.4% of CD45+ lymphocytes in unaffected and 0.2–4% in tumor tissue, were also insufficient for functional experiments. Here, PTPRC is linked to neoplasm.